Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,618 | 328 | 98.4% |
| Education | $89.81 | 2 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,455 | 88 | $0 (2024) |
| Janssen Biotech, Inc. | $922.33 | 58 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $872.51 | 66 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $405.85 | 25 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $245.95 | 8 | $0 (2024) |
| Gilead Sciences, Inc. | $224.60 | 12 | $0 (2023) |
| UCB, Inc. | $176.40 | 13 | $0 (2019) |
| GENZYME CORPORATION | $148.68 | 5 | $0 (2023) |
| CONMED Corporation | $136.34 | 2 | $0 (2024) |
| Endogastric Solutions, Inc | $121.04 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,184 | 105 | ABBVIE INC. ($695.18) |
| 2023 | $1,294 | 83 | AbbVie Inc. ($342.99) |
| 2022 | $566.96 | 38 | ABBVIE INC. ($134.91) |
| 2021 | $408.14 | 30 | Janssen Biotech, Inc. ($232.57) |
| 2020 | $188.24 | 8 | Janssen Biotech, Inc. ($74.99) |
| 2019 | $266.80 | 19 | Gilead Sciences, Inc. ($103.50) |
| 2018 | $628.85 | 37 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($157.09) |
| 2017 | $171.52 | 10 | AbbVie, Inc. ($64.34) |
All Payment Transactions
330 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.48 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.93 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.60 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: VIROLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $33.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/31/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $7.98 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $24.68 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $39.29 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.44 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/08/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/08/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.26 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $44.58 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,026 | 1,082 | $833,160 | $130,437 |
| 2022 | 14 | 1,030 | 1,112 | $807,964 | $127,431 |
| 2021 | 14 | 1,115 | 1,170 | $852,279 | $138,930 |
| 2020 | 13 | 984 | 1,062 | $634,435 | $113,091 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 188 | 189 | $254,529 | $43,049 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 176 | 221 | $54,366 | $21,839 | 40.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 119 | 119 | $40,817 | $14,678 | 36.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 178 | 178 | $226,950 | $14,229 | 6.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 35 | 35 | $36,260 | $7,023 | 19.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 81 | 82 | $87,986 | $6,457 | 7.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 95 | $16,625 | $6,246 | 37.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 22 | 22 | $22,836 | $4,429 | 19.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $8,822 | $3,228 | 36.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $19,722 | $2,664 | 13.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 29 | $4,176 | $1,894 | 45.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $18,590 | $1,613 | 8.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $3,653 | $1,455 | 39.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 13 | 13 | $37,219 | $1,443 | 3.9% |
| 91200 | Measurement of liver stiffness | Facility | 2023 | 12 | 12 | $444.00 | $97.02 | 21.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 11 | 11 | $165.00 | $92.40 | 56.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 177 | 177 | $238,242 | $38,121 | 16.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 175 | 218 | $46,998 | $20,501 | 43.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 134 | 134 | $45,962 | $16,339 | 35.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 180 | 180 | $229,628 | $15,454 | 6.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 32 | 32 | $33,152 | $6,529 | 19.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 99 | $14,272 | $6,422 | 45.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 70 | 71 | $76,183 | $4,946 | 6.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 30 | 31 | $12,206 | $4,628 | 37.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 44 | 67 | $9,408 | $3,967 | 42.2% |
About Dr. Aaron Benson, M.D
Dr. Aaron Benson, M.D is a Internal Medicine healthcare provider based in Mt Prospect, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164508453.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aaron Benson, M.D has received a total of $5,708 in payments from pharmaceutical and medical device companies, with $2,184 received in 2024. These payments were reported across 330 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,618).
As a Medicare-enrolled provider, Benson has provided services to 4,155 Medicare beneficiaries, totaling 4,426 services with total Medicare billing of $509,889. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Mt Prospect, IL
- Active Since 10/28/2006
- Last Updated 04/26/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1164508453
Products in Payments
- STELARA (Biological) $820.24
- ENTYVIO (Biological) $655.42
- RINVOQ (Biological) $439.80
- SKYRIZI (Biological) $434.90
- DUPIXENT (Biological) $394.63
- XIFAXAN (Drug) $256.66
- Entyvio (Biological) $194.03
- Humira (Biological) $186.11
- Cimzia (Drug) $176.40
- CREON (Drug) $150.09
- CONMED BILIARY (Device) $136.34
- ESOPHYX (Device) $121.04
- OCALIVA (Drug) $112.13
- UCERIS (Drug) $112.09
- SUCRAID (Drug) $98.57
- ZEPOSIA (Drug) $94.64
- TREMFYA (Drug) $89.80
- XELJANZ (Drug) $88.50
- LINZESS (Drug) $75.48
- HUMIRA (Biological) $69.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mt Prospect
Michelle Seo, Md, MD
Internal Medicine — Payments: $532.26
Thomas Reese, M.d, M.D
Internal Medicine — Payments: $155.55
Dr. Malkan Patel, D.o., M.s, D.O., M.S
Internal Medicine — Payments: $44.20
Dr. Andreas Seidler, Md, MD
Internal Medicine — Payments: $25.56
Dr. Mark Shields, M.d, M.D
Internal Medicine — Payments: $22.36
Dr. Evans Sirois, D.o, D.O
Internal Medicine